Sign in
4

Changes in Ownership

OptimizeRx Corp Filed Acc 0001628280-24-052522

CFO/COO acquired 41,408 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Stelmakh Edward CFO/COO 2024-12-23 Grant or award +41,408 97,295 D
Derivatives
Stelmakh Edward CFO/COO 2024-12-23 Grant or award · Stock Option +77,742 77,742 D
Loading xslF345X05/wk-form4_1735336822.xml…